New targeted therapy for treatment of serious form of skin cancer approved in Canada
KCBD,
SOURCE Roche Canada CotellicTM in combination with Zelboraf® designed to inhibit cancer growth in metastatic melanoma…
SOURCE Roche Canada CotellicTM in combination with Zelboraf® designed to inhibit cancer growth in metastatic melanoma…
SOURCE Roche Canada CotellicTM in combination with Zelboraf® designed to inhibit cancer growth in metastatic melanoma…
SOURCE Roche Canada CotellicTM in combination with Zelboraf® designed to inhibit cancer growth in metastatic melanoma…
SOURCE Roche Canada CotellicTM in combination with Zelboraf® designed to inhibit cancer growth in metastatic melanoma…